JPRN-C000000200未知未知
Therapeutic angiogenesis with acidic gelatin hydrogel microspheres incorporating fibroblast growth factor-2 for critical limb ischemia - Therapeutic angiogenesis with acidic gelatin hydrogel microspheres incorporating fibroblast growth factor-2 for critical limb ischemia
试验速览
- 阶段
- 未知
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 35years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Hypersensitivity for gelatin hydrogel 2.Serious medical co-morbidities 3.Alcoholism or other drug dependence within 3 months 4.Malignancy within 5 years 5.Possibility of malignancy 6.Operations within 3 months 7.Severe diabetic retinopathy 8.Pregnant woman, lactating woman 9.Vascular reconstruction within 2 months 10.Other complication unsuitable for the study
研究者
相似试验
未知
不适用
Therapeutic angiogenesis with acidic gelatin hydrogel microspheres incorporating fibroblast growth factor-2 for intermittent claudicatioJPRN-C000000201The University of Tokyo Hospital10
已完成
1 期
Clinical Study of Therapeutic Angiogenesis Using Hypoxic Preconditioned Peripheral Blood Mononuclear CellsPeripheral arterial occlusive diseaseJPRN-UMIN000018594Yamaguchi University Graduate School of Medicine Department of Surgery and Clinical Science7
已完成
不适用
Therapeutic Angiogenesis using Autologous Bone-Marrow Mononuclear Cells ImplantatioCLI(Critical limb ischemia) (ASO, Buerger disease, Collagen disease)JPRN-UMIN000023282Kyoto Prefectural University School of Medicine120
暂停
不适用
Therapeutic angiogenesis using bone marrow-derived mononuclear cells implantation for critical limb ischemiawith Buerger's diseasecritical limb ischemia caused by Buerger's diseasecritical limb ischemia, Buerger'a diseaseJPRN-jRCTb050190082Matoba Satoaki25
尚未招募
不适用
Therapeutic angiogenesis using autologous bone marrow mononuclear cells implantation for Buerger diseaseCLI(Critical limb ischemia) (Buerger disease)JPRN-UMIN000027383Kyoto Prefectural University School of Medicine25